Bridge joins the Elation Health Partner Hub to Elevate Patient Engagement for Elation EHR Users
The award-winning BridgeInteract patient engagement platform gives Elation customers a turnkey suite of self-service tools that reduce administrative overhead and deepen patient relationships.
DALLAS, June 19, 2025 /PRNewswire/ -- Bridge, a leader in white-labeled patient engagement technology, today announced a new partnership with Elation Health, the clinical–first Electronic Health Record (EHR) platform trusted by more than 30,000 primary-care providers.
The BridgeInteract Patient Engagement Platform is now a member of the Elation Partner Hub, Elation's partner marketplace. The collaboration embeds BridgeInteract's robust patient engagement capabilities directly into Elation, empowering practices to streamline intake, scheduling, messaging, and medical records access—all from a single, fully integrated experience.
BridgeInteract is already in use across various Elation EHR customers who were seeking a highly customizable and robust patient engagement solution.
This platform integration gives Elation's EHR users tools to boost efficiency and patient care. Mobile-ready self-service features let patients actively participate in routine care management, saving staff time. With a single operational workflow and real-time, bi-directional data flow, BridgeInteract eliminates manual entry and reduces errors. This all-in-one, customer-branded solution easily integrates into the Elation platform, streamlining operations and strengthening patient relationships.
Mobile-ready: Mobile-friendly self-service tools make it simple for patients to book visits, complete forms, and communicate with their care team on their schedule
One workflow, zero double-entry: Data moves bi-directionally between BridgeInteract and Elation in real time, eliminating manual work and data entry errors
Built with open APIs: Elation's modern, developer-friendly API gives BridgeInteract deep, native access to the EHR, enabling immediate, rapid integration and a clear, scalable path for future enhancements without costly custom work
All-in-one simplicity: Practices avoid a patchwork of piecemealed solutions; BridgeInteract delivers everything in a single, customer-branded solution that integrates seamlessly inside the Elation workflow
Customizable for unique care models: Bridge's modular architecture adapts to advanced primary care, employer health, and other specialized service lines, delivering workflows tailored to each organization's exact needs
"We're thrilled to partner with Elation Health, whose clinical-first philosophy mirrors our commitment to intuitive design and measurable outcomes," added John Deutsch, CEO of Bridge. "Together we're delivering a proven, scalable solution that improves care continuity and drives practice growth."
About Bridge
Bridge, makers of the BridgeInteract® platform, has been transforming patient engagement since 2014 with scalable, ONC-certified solutions that can be white-labeled for any healthcare brand. The platform's mobile-ready and modular architecture lets organizations quickly deploy intake, scheduling, secure messaging, medical records access, and online bill pay—seamlessly integrated with the EHR and practice management system. Learn more at www.bridgeinteract.io or in the Elation Partner Hub.
About Elation Health
Elation Health is the technology platform for primary care success. Supporting 36,000 clinicians caring for more than 18 million Americans, Elation Health's AI-powered EHR and billing solutions are designed for delivering high-value personalized care. The company's focus on clinician experience makes the platform the most-trusted and highest-rated in its segment across various settings, through innovative collaboration, workflow, and AI implementation, all tailored to primary care. Learn more at elationhealth.com, LinkedIn, and X.
Media Contact:
Chad Van AlstinChad@envhs.com941-281-5821
View original content to download multimedia:https://www.prnewswire.com/news-releases/bridge-joins-the-elation-health-partner-hub-to-elevate-patient-engagement-for-elation-ehr-users-302485528.html
SOURCE Bridge
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Jefferson hopes to renew two levies
JEFFERSON — Village council voted to move forward with the renewal of two existing levies to help provide services to residents. The resolutions request the Ashtabula County Auditor certify the total current tax valuation and amount of revenue that would be generated for a 1.55-mill, five-year street light levy and a one-mill, five-year fire levy, to be placed on the November ballot. Council also approved a resolution to establish a K-9 fund to be used for all donations and revenues received for the upkeep and support of the dog. They also approved the hiring of Jeromey Cummins to a full-time detective/patrolman position. Jefferson Village Manager Steve Murphy said he was able to attend a local government conference early this month in Washington D.C. He said he was able to let state and federal officials know where the village is, and urge them to come visit. He said one of the topics of conversation was House Bill 335, which would eliminate property tax inside millage. Murphy said the proposal would cost the village $250,000-$300,000 a year.
CNN
32 minutes ago
- CNN
Two years after train derailment, NIH to commission longer-term health studies of East Palestine residents
The National Institutes of Health said Thursday that it will fund longer-term health studies of the residents of East Palestine, Ohio, after a 2023 train derailment that sent more than a million pounds of hazardous chemicals into the soil, water and air. The community has long asked the government to do more to help answer questions about the mental and physical effects of the disaster, which some people say they continue to struggle with more than two years later. The funding will be available through the National Institute of Environmental Health Sciences. In 2024, under the Biden administration, the institute funded six two-year rapid-response projects to study different aspects of exposures and health problems after the disaster. Those projects were worth more than $1 million in total. The new grants will award up to $10 million for one to three projects over the next five years. Vice President JD Vance, who was a senator from Ohio when the derailment occurred, pushed for the funding, the NIH said. 'NIH is working to ensure that the people of East Palestine and the surrounding communities are listened to, cared for, and get the answers they deserve,' NIH Director Dr. Jay Bhattacharya said in a news release. 'This multi-disciplinary research program will focus on public health tracking and surveillance of the community's health conditions to support health care decisions and preventive measures.' East Palestine resident Misti Allison, who ran for mayor after the disaster and campaigned for long-term health studies in the area, said she was pleasantly surprised by the announcement. She sits on the board of one of the current community health studies. 'This next level of funding will enable us to conduct comprehensive and high-impact studies that can truly make a difference in the area,' Allison said. She notes that the funding announcement mentions that the research will be co-developed with input from the community. 'This will really ensure that our concerns and needs are at the forefront,' she said. 'So that is really great.' More than two years after the disaster, there's been a surge in post-traumatic stress disorder symptoms, respiratory complaints and even some cancers, Allison said. Because cancers have many causes, however, it's difficult to tie those directly to chemical exposures from the derailment, she noted. Jessica Conard, whose son developed asthma a few months after breathing toxic fumes from the derailment, said the announcement brought 'a complicated mix of emotions.' 'We have had real symptoms now for 2½ years, and all we've received is gaslighting and dismissals from state, local and federal agencies,' Conard said. 'We still need an organized medical response, and this should have happened immediately after the disaster,' she said. 'This feels like a political afterthought. 'My hope is that this $10 million doesn't just fund another academic report that sits on the shelf without any actionable takeaways,' she said, 'We desperately need real medical support.' Allison said the community has advocated for an emergency declaration to activate special provisions for victims of environmental exposures that would enable residents to receive Medicare benefits to help pay for their ongoing health needs. 'These funds would be a lifeline for many families who are still grappling with health concerns and some economic hardship,' she said. Dr. Andrew Whelton, a civil and environmental engineer at Purdue University who helps communities assess the impacts of disasters, said the need for the funding is unfortunate. The government and community would have been better served if they'd made more money available up-front to prevent exposures to residents in the first place, he said, and inadequate indoor air testing allowed residents to be exposed to chemicals in their homes for months after the disaster. 'It's positive that there is funding to potentially help people investigate long-term health impact questions, but none of it would have been necessary if the right decisions were made and people in agencies didn't fail the public' in the first place, Whelton said. The NIH said it will accept applications for the East Palestine study grants until July 21.
Yahoo
33 minutes ago
- Yahoo
Seneca Stock Declines Following Lower Q4 Earnings Despite Sales Gain
Shares of Seneca Foods Corporation SENEA have lost 3.4% since the company reported its earnings for the quarter ended March 31, 2025. This compares to the S&P 500 Index's 0.7% decline over the same time frame. Over the past month, the stock lost 3.7% against the S&P 500's 0.9% rise. Seneca reported net sales of $345.8 million for the fourth quarter of fiscal 2025, up 12.3% from $307.9 million in the same quarter last year. However, net earnings were modest at $0.6 million, or $0.09 per share, against a net loss of $2.2 million or $0.32 per share, in the prior-year quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Full-year net sales rose 8.2% to $1.58 billion from $1.46 billion, driven by higher volumes, favorable mix and pricing actions. Despite the revenue increase, annual net earnings declined 34.9% to $41.2 million from $63.3 million. Earnings per share dropped 31.1% from $8.56 to $5.90 on a diluted basis. Gross margin as a percentage of net sales also compressed notably, from 6.7% to 4.5% for the quarter and from 12.9% to 9.5% for the year. Seneca's adjusted net earnings for the year, which exclude LIFO-related charges, came in at $67.1 million compared with $80.2 million a year ago — a 16.3% decline. This suggests core profitability deterioration despite higher sales, reflecting cost pressures. EBITDA was $136.9 million, down 18.1% from $167.3 million, while FIFO-adjusted EBITDA dropped 9.6% to $171.4 million from $189.6 million, both indicating a weaker operational performance compared to fiscal 2024. Segment-wise, the vegetable division continued to dominate, comprising 91.1% of the food packaging revenues, with canned vegetables alone accounting for 83.2% of total net sales. Canned vegetable sales rose to $1.31 billion in fiscal 2025 from $1.20 billion in 2024, a 9.1% increase. Frozen vegetables rose to $124.7 million from $120.8 million (up 3.2%), fruit products reached $92.4 million from $87.4 million (up 5.7%) and snacks rose to $14.9 million from $13.4 million (up 11.9%). The 'Other' category, including can and seed sales and aircraft operations, posted growth of 1% to $32.5 million from $32.2 million. Seneca Foods Corp. price-consensus-eps-surprise-chart | Seneca Foods Corp. Quote President and CEO Paul Palmby commented on the solid top-line performance despite adverse weather, tariff fluctuations and input cost inflation. Palmby highlighted that strong operating cash flow enabled a $297 million reduction in net debt year over year, which is a significant achievement in a high-cost environment. Nevertheless, he cautioned that high-cost inventories from the 2024 pack continued to compress margins, especially in the fiscal fourth quarter. Several factors weighed on margins and profitability during the fiscal year. The company faced elevated input costs across raw materials, packaging, transportation and labor. Although some cost pressures began to ease in fiscal 2025, they remained above historical levels. Additionally, Seneca struggled to fully pass on these costs to customers in a timely manner, leading to margin erosion. The decline in margins was primarily attributed to higher input costs — including raw materials, labor and distribution — which outpaced the benefits from pricing adjustments. SENEA's use of the LIFO inventory valuation method resulted in a significant charge of $34.5 million for the fiscal year, up 54.3% from $22.3 million in the prior fiscal year, reducing reported profitability. These elevated LIFO charges reflected the cost pressure of high-priced inventory carried into fiscal 2025. In addition, segment-specific dynamics such as commodity volatility and changing consumer demand played roles. The vegetable segment, which comprises 91.1% of food-related sales, faced margin compression even amid volume growth. Despite implementing sales price increases, Seneca acknowledged that these adjustments often lag behind cost escalation, especially in a competitive market landscape. Seneca also cited a rainy growing season as a challenge, likely impacting yields and increasing procurement and processing complexities. The seasonal nature of its operations, particularly in the third quarter, exacerbated cost management issues as inventories and accounts payable peaked during harvest cycles. Seneca did not provide formal earnings or sales guidance for fiscal 2026 in either the earnings press release or the 10-K filing. However, the company did highlight its ongoing efforts to manage costs through short-term supply contracts and operational efficiency initiatives. Management also suggested that certain cost pressures, such as labor and raw materials, had begun to stabilize during fiscal 2025, potentially easing some margin constraints in the near term. Management also highlighted ongoing investment in technology and logistics to drive future margin recovery. There were no acquisitions, divestitures or significant restructuring initiatives disclosed by management for the quarter ended March 31, 2025. SENEA's capital allocation focused on debt reduction, and no dividends were paid. Stock repurchases continued on a modest scale, with 9,891 Class A shares repurchased during February 2025 from the company's employee savings plan at an average price of $79.53 per share. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Seneca Foods Corp. (SENEA) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
